490 likes | 1.05k Vues
Catalytic, Asymmetric Synthesis of β-Lactams. Matt Windsor Gellman Group 10/19/06. Outline. Background and Applications Synthesis Gilman-Speeter Kinugasa Staudinger Potential Industrial Uses Conclusions. Synthesis by Staudinger.
E N D
Catalytic, Asymmetric Synthesis of β-Lactams Matt Windsor Gellman Group 10/19/06
Outline • Background and Applications • Synthesis • Gilman-Speeter • Kinugasa • Staudinger • Potential Industrial Uses • Conclusions
Synthesis by Staudinger • First to synthesize β-lactam core from diphenylketene and benzylideneaniline - +
Discovery of Penicillin • Discovered in 1928 • First used to treat patients in 1942 • Significantly lowered number of deaths and amputations caused by infected wounds in WWII
Penicillin’s Mode of Action • Prevents crosslinking of bacteria’s cell wall polymer strands (peptidoglycan) http://en.wikipedia.org/wiki/Peptidoglycan
Mechanism of Activity • -lactams act as inhibitors of serine proteases: • -lactamases • Prostate Specific Antigen • Thrombin • Human Cytomegalovirus • Elastase
Antibiotic Resistance via -Lactamases • -Lactamases able to remove acyl group, regenerate serine sidechain
Outline • Background and Applications • Synthesis • Gilman-Speeter • Kinugasa • Staudinger • Potential Industrial Uses • Conclusions
Common Methodologies • Enantiomerically pure substrates • Chiral auxiliaries
Gilman-Speeter Selectivity • Ternary complex: Li amide, chiral ligand, Li enolate ester • Screening of new, tridentate catalysts to replace amide base in complex
Kinugasa: Background • First reaction to give exclusively cis-lactam • Stoichiometeric use of copper under nitrogen
First Catalytic Kinugasa Reaction • Significant isomerization to trans lactam under basic conditions • Imine byproduct
Isomerization from cis to trans Isomerization rate depends on R: Ester > aryl > alkyl
Quaternary Center Hypothesis • Introduce electrophile and get quaternary center • Addition should be trans to C-4 substituent
Initial Quaternary Conditions • Standard reaction conditions gave negligible amount of product
Development of New Proton Sink • Replaced R3N base • New system generates acetophenone • Poor proton donor compared to trialkylammonium salt
Air Stable Kinugasa Catalyst • Cu(II) reagent stable under air • Cu(I) catalytic species
More Evidence for New Mechanism • Intermediate stabilized by electron withdrawing group (EWG)
Staudinger Mechanism • One of the most common methods toward -lactams • cis-Lactam predominant product in most reactions (can isomerize to get trans) • High background rate (spontaneous)
Reaction Control • In order to control reaction, had to first prevent spontaneous cyclization • Requires development of electron-deficient imine • Catalyst needed for reaction to proceed
Diastereoselective Catalyst • Rigidify transition state by using catalyst that is H-bond donor and acceptor • Selectivity lost in H-bonding solvent
Enantioselective Catalyst • Cinchona alkaloids used previously as enantioselective catalyst
Ketene Generation • Commonly use trialkylamine to dehydrohalogenate acyl chloride • Base can act as nucleophile to catalyze reaction racemically • Need non-nucleophilic, but strong thermodynamic base
Shuttle Deprotonation • Use weaker but faster base, have PS remove HCl and precipitate • BQ plays role of kinetically active base
Synthesis with Unique Ketenes • Oxygen substituted ketenes can not be synthesized with chiral auxiliaries
Will a Lewis Acid (LA) Increase Yield? • Intermediate reacting promiscuously • Need to activate imine or make intermediate more chemoselective • Four scenarios: coordinate to imine (A), enolate (B), both (C) or catalyst (D)
Indium as Lewis Acid • Increase in yield, small loss in diastereoselectivity
Variation of the Imine Substituent • Range of ketene and imine substituents in very good yield, ee
Control of cis or trans Product • cis/trans selection depends on N-protecting group!
trans Products From Anionic Catalyst • Negative charge, bulky counterion are key • No alkyl groups, work ongoing
Outline • Background and Applications • Synthesis • Rhodium Catalyzed • Gilman-Speeter • Kinugasa • Staudinger • Potential Industrial Uses • Conclusions
Industrial Uses: Zetia • Inhibitor of intestinal cholesterol absorption • Combined with Merck statin (ZOCOR ) and sold as Vytorin
Conclusions • Field still in its infancy • Primarily limited by substrate specificity • Enolate for Gilman-Speeter • Imine for Staudinger • Nitrone for Kinugasa • Better catalysts to maximize selectivity, yield
Shout Outs • Professor Sam Gellman • Gellman Group • Practice Talk Attendees • Lauren Boyle Claire Poppe • Maren Buck Chris Shaffer • Julee Byram Becca Splain • Alex Clemens Katherine Traynor • Richard Grant